Suchergebnisse - "Morrisette, Taylor"

PubPharm (87)

1

Updates in pulmonary drug-resistant tuberculosis pharmacotherapy : A focus on BPaL and BPaLM

enthalten in: Pharmacotherapy | 2024

von Holger, D. | Althubyani, A. | Morrisette, T. | +2

2

Eravacycline, the first four years : health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

enthalten in: Microbiology spectrum | 2024

von Kunz Coyne, A. | Alosaimy, S. | Lucas, K. | +29

3

Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy : A focus on BPaL and BPaLM

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2024

von Holger, D. | Althubyani, A. | Morrisette, T. | +2

4

Successful Eradication of a Highly Resistant Elizabethkingia anophelis Species in a Premature Neonate With Bacteremia and Meningitis

enthalten in: The Pediatric infectious disease journal | 2023

von Hartley, C. | Morrisette, T. | Malloy, K. | +3

5

Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Holger, D. | El Ghali, A. | Bhutani, N. | +12

6

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections : a retrospective, multicenter cohort of real-world health outcomes

enthalten in: Antimicrobial agents and chemotherapy | 2023

von El Ghali, A. | Morrisette, T. | Alosaimy, S. | +30

7

Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections

enthalten in: Pharmacotherapy | 2023

von Tran, N. | Morrisette, T. | Jorgensen, S. | +2

8

Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Morrisette, T. | Stamper, K. | Lev, K. | +5

9

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents : Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Alosaimy, S. | Lagnf, A. | Hobbs, A. | +30

CommentIn: Clin Infect Dis. 2023 Apr 17;76(8):1521-1522. - PMID 36550021

10

Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2023

von Tran, N. | Morrisette, T. | Jorgensen, S. | +2

1
2
3
4
5
6
7
8
9
Nächster »
[9]